How many blood-forming stem cells are present at birth to keep us supplied with blood cells for a lifetime? It is more than previously thought.
Prophylactic antibiotic therapy with levofloxacin is safe and effective for reducing treatment-related infections in pediatric leukemia patients.
The severity and complexity of chronic disease in adult survivors of childhood cancer suggest that a new approach to healthcare delivery is needed.
Childhood Solid Tumor Network offers the world’s largest and most comprehensive collection of scientific resources for studying pediatric solid tumors
Health provider recommendation most important predictor of HPV vaccination of adolescent and young adult survivors of childhood cancer.
Regulatory T cells show evidence of functional exhaustion in research that underscores the importance of immunometabolism for immune balance.
Identifying the basic cellular malfunction underlying ALS opens the pathway to developing treatments to prevent the disease by preserving neurons.
St. Jude researchers have found that cells of a deadly acute myeloid leukemia can be killed by blocking production of a molecular “battery.”
Dr. Kalodimos’ appointment will further strengthen basic science programs that serve as the foundation of discovery.
Agreement with Serum Institute of India to develop a vaccine for respiratory syncytial virus, a lower respiratory tract infection in infants and children.
Explore more research news
More Research News
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Courageous patients. Resolute doctors. Caring staff. Inventive scientists. Their voices come alive in Promise magazine.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Browse all scientific publications by St. Jude investigators in 2016.